Jacob Funds Inc.
About this Fund
Jacob Funds Inc. is a leading mutual fund company that has been at the forefront of asset management and investment solutions for decades, providing a comprehensive range of investment products to cater to the diverse needs of its clients. As a trusted name in the industry, Jacob Funds Inc. specializes in wealth management, offering a broad spectrum of mutual fund options, including equity, debt, hybrid, and money market funds, allowing investors to create a well-diversified portfolio that aligns with their financial goals and risk tolerance. The company's expertise in investment management enables it to craft tailored solutions that meet the unique requirements of its investors, whether they are seeking long-term capital appreciation, regular income, or a combination of both. Jacob Funds Inc. is committed to delivering exceptional investment experiences, leveraging its in-depth market research, rigorous risk management, and a disciplined approach to investment selection, ensuring that its clients' assets are managed with the utmost care and diligence. The company's systematic investment plan, or SIP, allows investors to invest a fixed amount of money at regular intervals, promoting a disciplined approach to investing and helping to reduce the impact of market volatility. By focusing on the needs of its investors, Jacob Funds Inc. has established itself as a reliable partner for those seeking to grow their wealth over the long term. The company's investment philosophy is built around a deep understanding of the markets, a commitment to transparency, and a passion for delivering outstanding results, which has earned the trust of its clients and established it as a reputable player in the mutual fund industry. With a strong foundation in asset management and a proven track record of performance, Jacob Funds Inc. has become the go-to destination for investors seeking to create a diversified investment portfolio that can help them achieve their financial objectives. The company's experienced team of investment professionals works closely with clients to understand their investment goals, risk appetite, and time horizon, providing personalized wealth management solutions that are tailored to meet their unique needs. By combining its expertise in mutual fund management with a client-centric approach, Jacob Funds Inc. has built a loyal client base that appreciates the company's commitment to delivering exceptional investment results and outstanding customer service. As a result, Jacob Funds Inc. has established itself as a trusted name in the mutual fund industry, with a reputation for integrity, expertise, and a unwavering commitment to helping its clients achieve their investment goals. The company's dedication to investment excellence and its focus on building long-term relationships with its clients have been the driving forces behind its success, enabling it to navigate the complexities of the financial markets and deliver value to its investors. By staying at the forefront of industry trends and developments, Jacob Funds Inc. is well-positioned to continue providing innovative investment solutions that meet the evolving needs of its clients, whether they are individual investors, institutional investors, or financial advisors. With its strong heritage, investment expertise, and client-centric approach, Jacob Funds Inc. remains a preferred choice for those seeking a reliable and trusted partner to help them achieve their investment objectives and secure their financial future.
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | DMAC DiaMedica Therapeutics Inc Since 2026-05-10 | 25253X207 | Equity (Common) |
3.44%
|
$0.56 | 70,730 |
| 2 | ESPR Esperion Therapeutics Inc Since 2026-05-10 | 29664W105 | Equity (Common) |
1.00%
|
$0.16 | 49,000 |
| 3 | HROW Harrow Inc Since 2026-05-10 | 415858109 | Equity (Common) |
3.99%
|
$0.65 | 12,047 |
| 4 | HRTX Heron Therapeutics Inc Since 2026-05-10 | 427746102 | Equity (Common) |
1.47%
|
$0.24 | 201,960 |
| 5 | STRR Star Equity Holdings Inc Since 2026-05-10 | 443787205 | Equity (Common) |
2.39%
|
$0.39 | 39,235 |
| 6 | IDYA Ideaya Biosciences Inc Since 2026-05-10 | 45166A102 | Equity (Common) |
1.64%
|
$0.27 | 8,335 |
| 7 | INVE Identiv Inc Since 2026-05-10 | 45170X205 | Equity (Common) |
1.65%
|
$0.27 | 85,555 |
| 8 | INGN Inogen Inc Since 2026-05-10 | 45780L104 | Equity (Common) |
1.57%
|
$0.26 | 42,000 |
| 9 | INSE Inspired Entertainment Inc Since 2026-05-10 | 45782N108 | Equity (Common) |
1.09%
|
$0.18 | 21,836 |
| 10 | IZEA IZEA Worldwide Inc Since 2026-05-10 | 46604H204 | Equity (Common) |
2.18%
|
$0.36 | 98,650 |
| 11 | LWLG Lightwave Logic Inc Since 2026-05-10 | 532275104 | Equity (Common) |
1.62%
|
$0.27 | 60,000 |
| 12 | NXDR Nextdoor Holdings Inc Since 2026-05-10 | 65345M108 | Equity (Common) |
1.13%
|
$0.18 | 106,000 |
| 13 | TRAK ReposiTrak Inc Since 2026-05-10 | 700215304 | Equity (Common) |
1.83%
|
$0.30 | 34,512 |
| 14 | XPL Solitario Resources Corp Since 2026-05-10 | 8342EP107 | Equity (Common) |
3.14%
|
$0.51 | 661,306 |
| 15 | TELA Tela Bio Inc Since 2026-05-10 | 872381108 | Equity (Common) |
0.64%
|
$0.10 | 119,775 |
| 16 | MAPS WM Technology Inc Since 2026-05-10 | 92971A109 | Equity (Common) |
2.09%
|
$0.34 | 511,788 |
| 17 | ATEC Alphatec Holdings Inc Since 2026-05-10 | 02081G201 | Equity (Common) |
2.35%
|
$0.38 | 28,200 |
| 18 | ARCT Arcturus Therapeutics Holdings Since 2026-05-10 | 03969T109 | Equity (Common) |
0.57%
|
$0.09 | 11,370 |
| 19 | BBBY BED BATH & BEYOND INC Since 2026-05-10 | 075896159 | Derivative |
0.01%
|
$0.00 | 2,300 |
| 20 | CABA Cabaletta Bio Inc Since 2026-05-10 | 12674W109 | Equity (Common) |
1.12%
|
$0.18 | 55,000 |
| 21 | CTLP Cantaloupe Inc Since 2026-05-10 | 138103106 | Equity (Common) |
4.04%
|
$0.66 | 63,325 |
| 22 | CDNA CareDx Inc Since 2026-05-10 | 14167L103 | Equity (Common) |
1.24%
|
$0.20 | 10,800 |
| 23 | CELC Celcuity Inc Since 2026-05-10 | 15102K100 | Equity (Common) |
8.61%
|
$1.41 | 12,609 |
| 24 | BBBY Bed Bath & Beyond Inc Since 2026-05-10 | 690370101 | Equity (Common) |
1.20%
|
$0.20 | 37,000 |
| 25 | RNAC Cartesian Therapeutics Inc Since 2026-05-10 | 816212302 | Equity (Common) |
0.77%
|
$0.12 | 16,500 |
| 26 | CDXS Codexis Inc Since 2026-05-10 | 192005106 | Equity (Common) |
0.84%
|
$0.14 | 136,875 |
| 27 | SCOR comScore Inc Since 2026-05-10 | 20564W204 | Equity (Common) |
2.57%
|
$0.42 | 61,805 |
| 28 | PRCH Porch Group Inc Since 2026-05-10 | 733245104 | Equity (Common) |
3.69%
|
$0.60 | 73,550 |
| 29 | DTIL Precision BioSciences Inc Since 2026-05-10 | 74019P207 | Equity (Common) |
1.21%
|
$0.20 | 47,089 |
| 30 | PRME Prime Medicine Inc Since 2026-05-10 | 74168J101 | Equity (Common) |
1.13%
|
$0.18 | 40,000 |